SDAD1P1: A Pseudogene and Potential Drug Target (G157489)

Target Name: SDAD1P1

NCBI ID: G157489

SDAD1P1

Other Name(s): SDA1 domain containing 1 pseudogene 1

SDAD1P1: A Pseudogene and Potential Drug Target

SDAD1P1 (short for short for SDAM-associated protein 1), is a protein that is expressed in various tissues of the body, including the brain, heart, and skeletal muscles. It is a member of the SDAM family, which is characterized by the presence of a specific domain called SDAM-like. SDAM-like domains are a type of transmembrane protein that are characterized by the presence of a specific protein domain, in this case, SDAM-like domains.

The SDAM-associated protein 1 gene has been identified and is located on chromosome 17, specifically on the X chromosome. It is a pseudogene, which means that it is a gene that does not encode a functional protein but instead serves as a carrier of a genetic signature. The SDAM-associated protein 1 gene is expressed in various tissues of the body, including the brain, heart, and skeletal muscles.

The protein encoded by the SDAM-associated protein 1 gene is a 14-kDa protein that is expressed in various tissues of the body. It is characterized by the presence of a specific domain called SDAM-like, which is responsible for the protein's unique structure and function. The SDAM-like domain is a transmembrane protein that is characterized by the presence of a specific protein domain, in this case, a leucine-rich repeat.

The SDAM-associated protein 1 gene has been studied extensively, and numerous studies have demonstrated its involvement in various cellular processes, including cell signaling, neurotransmission, and muscle contraction. For example, studies have shown that SDAM-associated protein 1 is involved in the regulation of muscle contractions, and that it plays a role in the development and maintenance of muscle mass.

In addition to its role in muscle biology, SDAM-associated protein 1 has also been shown to be involved in other cellular processes, including cell signaling and neurotransmission. For example, studies have shown that SDAM-associated protein 1 is involved in the regulation of cell proliferation, and that it plays a role in the development and maintenance of neural circuits.

Given the extensive involvement of SDAM-associated protein 1 in various cellular processes, it is a promising candidate for drug targeting. Studies have shown that SDAM-associated protein 1 can be effectively targeted with small molecules, and that this approach can lead to the inhibition of cell proliferation and the regulation of various cellular processes.

In conclusion, SDAM-associated protein 1 is a pseudogene that is characterized by the presence of a specific protein domain, in this case, the SDAM-like domain. It is expressed in various tissues of the body, including the brain, heart, and skeletal muscles, and has been shown to be involved in various cellular processes, including cell signaling, neurotransmission, and muscle contraction. Given its extensive involvement in various cellular processes, SDAM-associated protein 1 is a promising candidate for drug targeting.

Protein Name: SDA1 Domain Containing 1 Pseudogene 1

The "SDAD1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SDAD1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets